BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6411389)

  • 1. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.
    Schaison G; Couzinet B; Moatti N; Pertuiset B
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):541-9. PubMed ID: 6411389
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly.
    Rieu M; Girard F; Bricaire H; Binoux M
    J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between clinical and endocrinological features following transsphenoidal surgery of acromegaly. With special reference to somatomedin-C level].
    Osawa M; Kobayashi S; Takemae T; Nakagawa F
    Neurol Med Chir (Tokyo); 1988 Mar; 28(3):254-8. PubMed ID: 2457827
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acromegaly by transsphenoidal microsurgery.
    Giovanelli MA; Motti ED; Paracchi A; Beck-Peccoz P; Ambrosi B; Faglia G
    J Neurosurg; 1976 Jun; 44(6):677-86. PubMed ID: 818343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatomedin-C in active and successfully treated acromegaly.
    Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
    Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly presenting with diabetic ketoacidosis.
    Katz JR; Edwards R; Khan M; Conway GS
    Postgrad Med J; 1996 Nov; 72(853):682-3. PubMed ID: 8944212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications and results of pituitary radiotherapy after microsurgery in acromegaly. 15 cases].
    Guittard M; Kuttenn F; Valcke JC; Mauvais-Jarvis P
    Presse Med; 1987 Jun; 16(25):1217-21. PubMed ID: 2955371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the determination of somatomedins in acromegaly].
    Rieu M
    Presse Med; 1983 Sep; 12(31):1909-10. PubMed ID: 6226000
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secretion of growth hormone and insulin in patients with acromegaly].
    Ulrich E; Seige K; Schneyer U; Wilhelmsen E; Hädecke J
    Z Gesamte Inn Med; 1973 Mar; 28(5):141-2 passim. PubMed ID: 4350299
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
    J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the criteria for assessing the outcome of treatment in acromegaly.
    Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE
    Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly: selection parameters and operative results.
    Weiss MH
    Clin Neurosurg; 1980; 27():31-7. PubMed ID: 7273559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.